Insider · CIK 0001608578

Garner Elizabeth

Reports to the SEC for 2 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001608578

Forms 4 and 5

Insider transactions

39 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-11	KZRKezar Life Sciences, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,500 sh	—	—	0
2026-05-11	KZRKezar Life Sciences, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2026-05-11	KZRKezar Life Sciences, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2026-05-11	KZRKezar Life Sciences, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,779 sh	—	—	0
2026-05-11	KZRKezar Life Sciences, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−889 sh	—	—	0
2026-05-11	KZRKezar Life Sciences, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,600 sh	—	—	0
2026-05-11	KZRKezar Life Sciences, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,600 sh	—	—	0
2025-06-18	KZRKezar Life Sciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2024-06-20	KZRKezar Life Sciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2023-07-24	KZRKezar Life Sciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−17.8K sh	—	—	0
2023-07-24	KZRKezar Life Sciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17.8K sh	—	—	17,793
2023-07-24	KZRKezar Life Sciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,896 sh	—	—	0
2023-07-24	KZRKezar Life Sciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+8,896 sh	—	—	8,896
2023-07-24	KZRKezar Life Sciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−26K sh	—	—	0
2023-07-24	KZRKezar Life Sciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+26K sh	—	—	26,000
2023-07-24	KZRKezar Life Sciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−26K sh	—	—	0
2023-07-24	KZRKezar Life Sciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+26K sh	—	—	26,000
2023-06-15	KZRKezar Life Sciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+35K sh	—	—	35,000
2022-06-16	KZRKezar Life Sciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+26K sh	—	—	26,000
2021-06-28	KZRKezar Life Sciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+26K sh	—	—	26,000
2020-06-24	KZRKezar Life Sciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+8,896 sh	—	—	8,896
2019-12-18	KZRKezar Life Sciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+17.8K sh	—	—	17,793
2019-01-29	AGILE THERAPEUTICS INCEmployee Stock Option (Right to Buy)A Award	Sr. VP & Chief Medical Officer	AAward	+173K sh	—	—	172,600
2019-01-29	AGILE THERAPEUTICS INCEmployee Stock Option (Right to Buy)A Award	Sr. VP & Chief Medical Officer	AAward	+38.5K sh	—	—	38,500
2019-01-25	AGILE THERAPEUTICS INCM Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	+17.5K sh	—	—	47,800
2019-01-25	AGILE THERAPEUTICS INCRestricted Stock UnitsM Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	−17.5K sh	—	—	0
2019-01-24	AGILE THERAPEUTICS INCM Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	+18.6K sh	—	—	30,300
2019-01-24	AGILE THERAPEUTICS INCRestricted Stock UnitsM Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	−18.6K sh	—	—	17,500
2018-06-20	AGILE THERAPEUTICS INCEmployee Stock Option (Right to Buy)A Award	Sr. VP & Chief Medical Officer	AAward	+150K sh	—	—	150,000
2018-01-25	AGILE THERAPEUTICS INCM Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	+17.5K sh	—	—	17,500
2018-01-25	AGILE THERAPEUTICS INCF Tax Payment	Sr. VP & Chief Medical Officer	FTax Payment	−5,765 sh	$3.32	−$19.1K	11,735
2018-01-25	AGILE THERAPEUTICS INCRestricted Stock UnitsM Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	+17.5K sh	—	—	36,065
2018-01-24	AGILE THERAPEUTICS INCEmployee Stock Options (Right to Buy)A Award	Sr. VP & Chief Medical Officer	AAward	+107K sh	—	—	107,000
2018-01-24	AGILE THERAPEUTICS INCRestricted Stock UnitsA Award	Sr. VP & Chief Medical Officer	AAward	+18.6K sh	—	—	53,565
2017-01-25	AGILE THERAPEUTICS INCEmployee Stock Option (Right to Buy)A Award	Sr. VP & Chief Medical Officer	AAward	+100K sh	—	—	100,000
2017-01-25	AGILE THERAPEUTICS INCRestricted Stock UnitsA Award	Sr. VP & Chief Medical Officer	AAward	+35K sh	—	—	35,000
2016-02-08	AGILE THERAPEUTICS INCEmployee Stock Option (Right to Buy)A Award	Sr. VP & Chief Medical Officer	AAward	+90K sh	—	—	90,000
2015-02-19	AGILE THERAPEUTICS INCEmployee Stock Option (Right to Buy)A Award	Sr. VP & Chief Medical Officer	AAward	+50K sh	—	—	50,000
2015-02-19	AGILE THERAPEUTICS INCEmployee Stock Option (Right to Buy)A Award	Sr. VP & Chief Medical Officer	AAward	+50K sh	—	—	50,000

Recent filings

Accepted (ET)
May 114
Garner Elizabeth0001608578-26-000002
SEC(opens sec.gov)
Jun 234
Garner Elizabeth0001415889-25-017968
SEC(opens sec.gov)
Jun 214
Garner Elizabeth0001415889-24-017838
SEC(opens sec.gov)
Jul 264
Garner Elizabeth0001209191-23-043433
SEC(opens sec.gov)
Jun 164
Garner Elizabeth0001209191-23-037928
SEC(opens sec.gov)
Jun 174
Garner Elizabeth0001209191-22-038039
SEC(opens sec.gov)
Jun 304
Garner Elizabeth0001209191-21-044083
SEC(opens sec.gov)

Companies

Address

C/O KEZAR LIFE SCIENCES, INC. 4000 SHORELINE COURT, SUITE 300

SOUTH SAN FRANCISCO, CA, 94080